Last reviewed · How we verify

MED2005 — Competitive Intelligence Brief

MED2005 (MED2005) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical phosphodiesterase inhibitor or vasodilator. Area: Urology / Sexual Health.

phase 3 Topical phosphodiesterase inhibitor or vasodilator Urology / Sexual Health Small molecule Live · refreshed every 30 min

Target snapshot

MED2005 (MED2005) — Futura Medical Developments Ltd.. MED2005 is a topical cream formulation designed to enhance erectile function through local application to penile tissue.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
MED2005 TARGET MED2005 Futura Medical Developments Ltd. phase 3 Topical phosphodiesterase inhibitor or vasodilator

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical phosphodiesterase inhibitor or vasodilator class)

  1. Futura Medical Developments Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). MED2005 — Competitive Intelligence Brief. https://druglandscape.com/ci/med2005. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: